Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd. (CHGCF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
chgcf · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - General · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Chugai Pharmaceutical Co., Ltd.You CHGCF | $77.2B | 27.17x | +18.2% | $274.77 |
 CSL Limited CMXHF | $33.8B | 26.29x | +14.3% | $6.20 |
 Daiichi Sankyo Company, Limited DSKYF | $29.5B | 20.69x | -10.0% | $141.33 |
 Daiichi Sankyo Company, Limited DSNKY | $29.2B | 19.10x | -16.9% | $148.91 |
 GSK plc GLAXF | $94.4B | 12.94x | -43.7% | $1.41 |
 HOYA Corporation HOCPY | $54.5B | 34.72x | +51.0% | $788.79 |
 Ipsen S.A. IPSEY | $61.8B | 24.22x | +5.3% | $1.28 |
Industry Average 6 peers with valid PE | — | 22.99x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Chugai Pharmaceutical Co., Ltd. (CHGCF) measures how much investors pay for each dollar of the company's trailing earnings. CHGCF's current PE ratio of 27.17x is calculated by dividing its stock price of $46.93 by its TTM earnings per share of $274.77.
Frequently asked questions
CHGCF pe ratio · 6 questionsCHGCF's current PE ratio is 27.17x as of 2026-06-09, based on a stock price of $46.93 and TTM EPS of $274.77. Data sourced from Financial Modeling Prep via CHGCF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Chugai Pharmaceutical Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09